Development

Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control

388. Weller, K.+, Donoso, T., Magerl, M., Aygören-Pürsün, E., Staubach, P., Martinez-Saguer, I., Hawro, T., Altrichter, S., Krause, K., Siebenhaar, F., Metz, M., Zuberbier, T., Freier, D., and Maurer, M.: Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control. J. Allergy Clin. Immunol. Pract. 2020: 8; 2050-2057. IF: 8.86

o.388

Development of the angioedema control test (AECT) – a patient reported outcome measure that assesses disease control in patients with recurrent angioedema

387. Weller, K.+, Donoso, T., Magerl, M., Aygören-Pürsün, E., Staubach, P., Martinez-Saguer, I., Hawro, T., Altrichter, S., Krause, K., Siebenhaar, F., Metz, M., Zuberbier, T., Freier, D., and Maurer, M.: Development of the angioedema control test (AECT) – a patient reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy 2020: 75; 1165-1177. IF: 13.15

o.387

Murine and human mast cell progenitors

106. Schmetzer, O., Valentin, P., Church, M. K., Maurer, M., and Siebenhaar, F.: Murine and human mast cell progenitors. Eur. J. Pharmacol. 2016: 778; 2-10. IF: 2.89

r.106